Previous 10 | Next 10 |
BEDFORD, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global joint preservation company in early intervention orthopedics, today announced that it has filed its preliminary proxy materials with the Secu...
2023-03-24 12:03:47 ET The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event. For further details see: Anika Therapeutics (ANIK) Presents at the Sidoti Small-Cap Virtual Conference - Slideshow
2023-03-21 11:12:35 ET The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event. For further details see: Anika Therapeutics (ANIK) Presents At Canaccord Genuity Musculoskeletal Conference 2023 - Slideshow
Recently Commenced Full Market Release of X-Twist™ Fixation System, a Cornerstone Product in Anika’s Sports Medicine Portfolio RevoMotion™ Reverse Shoulder Arthroplasty System Now in Limited Market Release in U.S. OVOMotion ® with Inlay Glenoid Total Should...
2023-03-06 19:54:45 ET The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Anika Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation
2023-03-06 19:48:08 ET Anika Therapeutics, Inc. (ANIK) Q4 2022 Earnings Conference Call March 6, 2023 05:00 PM ET Company Participants Mark Namaroff - VP, IR, ESG and Corporate Communications Cheryl Blanchard - President & CEO Mike Levitz - EVP & CFO ...
2023-03-06 16:09:03 ET Anika Therapeutics press release ( NASDAQ: ANIK ): Q4 Non-GAAP EPS of -$0.21 beats by $0.01 . Revenue of $39.6M (+10.6% Y/Y) beats by $1.89M . The Company expects its overall revenue for fiscal year 2023 to be between $158 million and $16...
Delivered Fourth Quarter Revenue Growth of 11% and Full Year 2022 Revenue Growth of 6% Completed First Surgeries and Initiated Limited Market Release of New RevoMotion™ Reverse Shoulder Arthroplasty System Commenced Full Market Release of X-Twist™ Fixation System i...
2023-03-05 17:35:14 ET Major earnings expected after the bell on Monday include: Nutanix ( NTNX ) Cara Therapeutics ( CARA ) Trip.com Group Limited ( TCOM ) AeroVironment ( AVAV ) Intrepid Potash ( IPI ) For further details see: Notable ea...
2023-03-05 17:35:00 ET Anika Therapeutics ( NASDAQ: ANIK ) is scheduled to announce Q4 earnings results on Monday, March 6th, after market close. The consensus EPS Estimate is -$0.22 (+4.3% Y/Y) and the consensus Revenue Estimate is $37.71M (+5.3% Y/Y). Over the last 2...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...